Biostar Pharmaceuticals, Inc. (BSPM)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.87-1.19 (-29.31%)
At close: 4:00 PM EDT
People also watch:
SKBISPUDHRMCALICCCL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open3.20
Prev Close4.06
Bid2.68 x 1300
Ask3.49 x 300
Day's Range2.64 - 3.20
52wk Range1.08 - 6.59
1y Target EstN/A
Market Cap6.35M
P/E Ratio (ttm)-0.25
Beta2.12
Volume517,493
Avg Vol (3m)1,054,404
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • PR Newswire2 days ago

    Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2016

    XIANYANG, China, Aug. 22, 2016 /PRNewswire/ - Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and ...

  • BioStar Pharmaceuticals, Inc. :BSPM-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016
    Capital Cube2 months ago

    BioStar Pharmaceuticals, Inc. :BSPM-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016

    Click here to see latest analysisBioStar Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of BioStar Pharmaceuticals, Inc. – Nature’s Sunshine Products, Inc., Emisphere Technologies, Inc., ProPhase Labs, Inc. and USANA Health Sciences, Inc. (NATR-US, EMIS-US, PRPH-US and USNA-US) that have also reported […] (Read more...) The post BioStar Pharmaceuticals, Inc. :BSPM-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 appeared first on CapitalCube.

  • Why Are These Five Stocks Trending Today?
    Insider Monkey2 months ago

    Why Are These Five Stocks Trending Today?

    Markets are getting hammered as the shocked investors react to the UK’s decision to bid farewell to the European Union. International markets have started to feel the heat and immediate ramifications of the referendum’s results after which the UK is set to embark on a road teeming with uncertainties. Investors are also closely watching some […]